British data show that using the therapeutic properties of cannabis improves quality of life

The findings from the UK team support an initial analysis published in 2021 based on the Medical Cannabis Registry, which found statistically significant improvements in patient disease scores in pain, anxiety, sleep and overall quality of life. 1 and 3 months after treatment.

“ Ancient use of cannabis for pain relief ” has a long history. Only the experience of using the plant as an anesthetic during surgical operations has more than 3000 years . Not surprisingly, the therapeutic properties of the plant are widely used to relieve or treat pain in a natural way, without any consequences for the health of patients (unlike analgesic therapy, which is based on the possibility of using various kinds of poppy derivatives). Analyzing the “ Trends in the global hemp market ”, as well as statistical data characterizing the market for the therapeutic properties of hemp in the USA, Australia, Canada, Germany, Israel , as well as a number of other economically developed countries, we can conclude that more than half of patients during hemp therapy use precisely the analgesic properties of the hemp plant. Therefore, the confirmation of the above thesis with statistical indicators obtained from the “foggy Albion” once again indicates which particular direction related to the use of the therapeutic properties of cannabis is most in demand by the patient/consumer.

Data from a UK registry that aggregates results from prescription cannabis use indicates a statistically significant improvement in patients' health-related quality of life. The UK Medical Cannabis Registry, run by Sapphire Medical, provides details on who is the largest patient group in the country receiving medical cannabis.

Analysis of problems using the therapeutic properties of the plant, which were reported by the patients registered in the Registry, revealed a statistically significant improvement in health-related quality of life at one, three and six months after treatment. The most common primary diagnoses addressed by the therapeutic properties of the hemp plant were chronic and neuropathic pain. In addition, the anxiety of patients using the therapeutic properties of the hemp plant is noted. According to the reviewers of the UK data, “All patients at baseline had an average anxiety score consistent with a diagnosis of generalized anxiety disorder. At follow-up, the mean score dropped to a level below clinically significant.”

Sapphire Medical says their findings suggest that, in addition to condition-specific changes, medical cannabis can also affect symptoms in patients with chronic health problems. In particular, it was noted that almost all patients using the therapeutic properties of cannabis experienced an improvement in the quality of sleep.

The findings from the UK team support an initial analysis published in 2021 based on the Medical Cannabis Registry, which found statistically significant improvements in patient disease scores in pain, anxiety, sleep and overall quality of life. 1 and 3 months after treatment.

Commentary of the specialists of the Association “Ukrainian Industrial Hemp”

In the UK, doctors have been able to prescribe medicinal products based on the therapeutic properties of cannabis to patients under certain circumstances since 2018, after public attention was drawn to the case of a young man suffering from epilepsy. The case of Billy Caldwell, who suffers from the above chronic neurological disease, led to a revision of British laws on the possibilities of using the therapeutic properties of the hemp plant.

Given the fact that our country has developed formulations of various kinds of additives that relieve pain, as well as solve health problems that lead to acute or chronic pain, the statistical indicators of our foreign colleagues, who speak of a huge market for products based on It may be assumed that the possibility of pain relief should be of interest to both patients and manufacturers of end products (for example, dietary supplements or food products), which will contain non-narcotic cannabinoids in their composition that solve this particular problem of the human body.